Skip to main content
Clinical Trials/ACTRN12624000166572
ACTRN12624000166572
Not Yet Recruiting
N/A

A pilot study to investigate the feasibility of a combined exercise and nutrition prehabilitation program for patients with endometrial cancer scheduled for surgery

King Edward Memorial Hospital0 sites20 target enrollmentFebruary 22, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
King Edward Memorial Hospital
Enrollment
20
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 22, 2024
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Low grade (grade 1\) endometrioid endometrial adenocarcinoma
  • 2\.Presumed early stage (Federation of Gynecology and Obstetrics stage 1A) on physical
  • examination and imaging (CT chest, abdomen, and pelvis)
  • 3\.At least one of the following cardiovascular risk factors: overweight (BMI greater than or
  • equal to 25kg/m2\) or obese (BMI greater than or equal to 30kg/m2\), hypertension, type
  • 2 diabetes, hypercholesterolaemia, self\-reported physical inactivity (less than 150
  • minutes per week of moderate activity such as walking, gardening, swimming, cycling,
  • gym), smoking
  • 4\.Planned to undergo definitive surgery (total hysterectomy, bilateral salpingo\-
  • oophorectomy \+/\- sentinel lymph node biopsies)

Exclusion Criteria

  • 1\.Medical contraindication to exercise or the use of a very low\-calorie diet, including
  • physical impairments, lactation, presence of porphyria, severe hepatic disease,
  • advanced renal disease, unstable cardiac disease (recent myocardial infarction or
  • unstable angina), type 1 diabetes mellitus, overt psychosis, alcoholism, or drug abuse
  • 2\.Patients on lithium, corticosteroids, anticonvulsants (although not a contraindication to
  • Optifast, requires extra monitoring beyond the scope of this study)
  • 3\.Evidence of extra\-uterine disease clinically or on medical imaging
  • 4\.Histological cell types including serous, clear cell, carcinosarcoma, sarcoma, de\-
  • differentiated
  • 5\.Moderately differentiated or poorly differentiated (grades 2 and 3\) endometrioid

Outcomes

Primary Outcomes

Not specified

Similar Trials